文献速递瓣膜病与结构性心脏病冠心病

慢性肾脏病合并主动脉瓣狭窄的评估与管理:美国心脏协会科学声明

Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart Association.
PubMed 文献 · Circulation · 2021-05-13

该科学声明由美国心脏协会发布,聚焦慢性肾脏病(CKD)合并主动脉瓣狭窄的评估与管理。声明指出,此类患者因被随机试验排除,管理决策多基于回顾性和观察性证据,并总结了其流行病学与病理生理特征、无创影像学价值、外科与经导管主动脉瓣置换的风险及围术期多学科管理。

要点

  • CKD患者主动脉瓣狭窄更常见、进展更快且更不可预测。
  • CKD与主动脉瓣置换术后短期和长期结局更差相关。
  • 晚期CKD和终末期肾病患者被排除在随机试验外,决策需依赖观察性证据。

核心结论

  • CKD合并主动脉瓣狭窄是临床挑战,需基于回顾性和观察性证据进行复杂管理决策。
  • 声明提供外科与经导管主动脉瓣置换的文献综述,以指导瓣膜置换方式和人工瓣膜选择。
  • 强调围术期管理及心肾多学科协作团队方法。

研究设计与样本

  • 美国心脏协会(AHA)科学声明。
  • 针对被随机试验排除的晚期CKD和终末期肾病患者,基于回顾性和观察性证据进行总结。

主要发现

  • 主动脉瓣狭窄在CKD中更普遍,进展更快且不可预测。
  • CKD的存在与主动脉瓣置换术后更差的短期和长期结局相关。
  • 声明总结了CKD背景下主动脉瓣狭窄的流行病学和病理生理特征,并评估超声心动图及高级影像技术的预后信息。

临床怎么用

  • 临床医生面对晚期CKD和终末期肾病合并主动脉瓣狭窄患者时,需依据回顾性和观察性证据做管理决策。
  • 选择主动脉瓣置换方式及人工瓣膜时参考声明对现有文献的批判性综述。
  • 围术期管理采用心肾多学科协作团队方法。

局限性

  • 晚期CKD和终末期肾病患者被排除在随机试验之外,证据主要来自回顾性和观察性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aortic stenosis with concomitant chronic kidney disease (CKD) represents a clinical challenge. Aortic stenosis is more prevalent and progresses more rapidly and unpredictably in CKD, and the presence of CKD is associated with worse short-term and long-term outcomes after aortic valve replacement. Because patients with advanced CKD and end-stage kidney disease have been excluded from randomized trials, clinicians need to make complex management decisions in this population that are based on retrospective and observational evidence. This statement summarizes the epidemiological and pathophysiological characteristics of aortic stenosis in the context of CKD, evaluates the nuances and prognostic information provided by noninvasive cardiovascular imaging with echocardiography and advanced imaging techniques, and outlines the special risks in this population. Furthermore, this statement provides a critical review of the existing literature pertaining to clinical outcomes of surgical versus transcatheter aortic valve replacement in this high-risk population to help guide clinical decision making in the choice of aortic valve replacement and specific prosthesis. Finally, this statement provides an approach to the perioperative management of these patients, with special attention to a multidisciplinary heart-kidney collaborative team-based approach.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Shroff GR, Bangalore S, Bhave NM, et al. Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart Association. Circulation. 2021. PMID: 33980041. doi:10.1161/CIR.0000000000000979

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。